LILLY-F1D-JE-BMAC

Study Sponsor: Lilly

Study Title

Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients with Manic or Mixed Episode of Bipolar I Disorder

Medicine or Vaccine (generic name)

Olanzapine

Sponsor Identification Number

F1D-JE-BMAC

Trial Registry Identification Number(#'s)

Not available

Medical Condition

Bipolar Disorder

Phase

Phase 3

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Not available

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies. The annotated case report form is not available. A blank case report form will be provided.

Date Added to this Site

September 2014